May 21, 2026
6 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
GLP-1s demonstrate ‘large’ & ‘consistent’ protective effects against cancer metastases
CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual Meeting.A database analysis of individuals diagnosed with stage I to stage III cancers showed those who used GLP-1 medications had lower risk for developing metastatic disease than those who used dipeptidyl peptidase-4
1,693 words~8 min read
